NewtekOne, Inc. has been selected to participate in the inaugural Emerging Company Pavilion at the 2026 Sohn New York Investment Conference, held on May 12 at Jazz at Lincoln Center. This selection highlights NewtekOne's strong market profile and growth in financial services for independent business owners. The event gathers top investors and offers NewtekOne a platform to showcase its technology-driven financial solutions to a sophisticated investor audience. This opportunity could enhance NewtekOne's visibility and attract investment interest as it continues to expand its unique financial services platform.
Slate Medicines, a biotech firm focused on migraine treatments, has appointed Mark W. Hahn to its Board of Directors. Hahn brings over 25 years of experience in life sciences, including leading companies through financial milestones and FDA approvals...
The global clinical trials market is projected to grow from $135.51 billion in 2026 to $176.32 billion by 2030, at a CAGR of 6.8%. Growth is fueled by advances in AI-enabled trial design, decentralized and hybrid trial platforms, and increasing deman...
The global hybrid robots market is projected to grow from $5.68 billion in 2026 to $10.03 billion by 2030, with a CAGR of 15.3%. Growth is fueled by advances in AI, autonomous operations, and smart manufacturing, alongside rising demand for robots in...
The global warehouse shuttle software market is projected to grow from $1.57 billion in 2026 to $2.66 billion by 2030, with a CAGR of 14.1%. Growth is fueled by rising e-commerce, warehouse automation, AI-driven orchestration, and robotic material ha...
The global nucleating and clarifying agents market, valued at $426.33 million in 2025, is projected to grow at a CAGR of 6.8% to reach $868.84 million by 2035. Growth is fueled by rising demand for high-clarity polypropylene packaging, especially in ...
